title: [Generalized Castleman's disease associated with Kaposi's sarcoma].
authors.forename: J C
authors.initials: JC
authors.lastname: Reverter
authors.forename: B
authors.initials: B
authors.lastname: Nomdedeu
authors.forename: E
authors.initials: E
authors.lastname: Martín Ortega
authors.forename: C
authors.initials: C
authors.lastname: Llebaría
authors.forename: J
authors.initials: J
authors.lastname: Palou
authors.forename: C
authors.initials: C
authors.lastname: Rozman
mesh_terms: D005871:Castleman Disease / Q000150:complications* / Q000188:drug therapy; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D005534:Foot Diseases / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007890:Leiomyosarcoma; D008297:Male; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary; D011379:Prognosis; D012514:Sarcoma, Kaposi / Q000150:complications*
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide
vernacular_title: Enfermedad de Castleman generalizada asociada a sarcoma de Kaposi.